Koninklijke Philips (PHG) Depreciation & Amortization (CF) (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Depreciation & Amortization (CF) came in at $310.2 million in Q1 2026, up 6.86% year-on-year from $290.3 million in Q1 2025, and down 76.31% quarter-over-quarter from $1.3 billion in Q4 2025.
Koninklijke Philips (PHG) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Koninklijke Philips' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $310.2 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 6.86% year-over-year to $310.2 million in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 8.04% decrease from a year earlier, with the FY2023 full-year figure at $1.4 billion, changed N/A from the prior year.
- Depreciation & Amortization (CF) fell to $310.2 million in Q1 2026 per PHG's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.6 billion in Q4 2022 and bottomed at $290.3 million in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $742.7 million (2022), against an average of $830.6 million.
- Biggest YoY gain for Depreciation & Amortization (CF) was 9.48% in 2024; the steepest drop was 44.84% in 2024.
- Year by year, Depreciation & Amortization (CF) stood at $1.6 billion in 2022, then fell by 16.99% to $1.4 billion in 2023, then rose by 9.48% to $1.5 billion in 2024, then fell by 11.84% to $1.3 billion in 2025, then plunged by 76.31% to $310.2 million in 2026.
- Per Business Quant, the three latest PHG Depreciation & Amortization (CF) figures stand at $310.2 million (Q1 2026), $1.3 billion (Q4 2025), and $989.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310.25 Mn |
| Mar 31, 2026 | 310.25 Mn |
| Dec 31, 2025 | 1.31 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Sep 30, 2025 | 989.02 Mn |
| Sep 30, 2025 | 989.02 Mn |
| Jun 30, 2025 | 301.10 Mn |
| Jun 30, 2025 | 301.10 Mn |
| Mar 31, 2025 | 290.32 Mn |
| Mar 31, 2025 | 290.32 Mn |
| Dec 31, 2024 | 1.49 Bn |
| Dec 31, 2024 | 1.49 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 369.37 Mn |
| Jun 30, 2024 | 369.37 Mn |
| Mar 31, 2024 | 320.48 Mn |
| Mar 31, 2024 | 320.48 Mn |
| Dec 31, 2023 | 1.36 Bn |
| Dec 31, 2023 | 1.36 Bn |